// App-Quantinova.ai

STEM-22 : EFFECT OF A SRC INHIBITORY PEPTIDE BASED ON CONNEXIN43 ON NEURAL STEM CELLS WITH GLIOMA-DRIVER MUTATIONS

Researchers

Presenter

  • Andrea Álvarez-Vázquez

Principal Investigators

  • Laura San-Segundo

  • Pilar Cerveró-García

  • Raquel Flores-Hernández

  • Claudia Ollauri-Ibáñez

  • Berta Segura-Collar

  • Pilar Sanchez-Gomez

  • Steven M Pollard

  • Arantxa Tabernero

Medical Centers

  • Neuroscience Institute of Castilla y León (INCyL), Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain

  • Neuro-Oncology Unit, Health Institute Carlos III, Madrid, Spain

  • Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom

  • Centre for Cancer Research-IBMCC (CSIC), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain

Locations

  • Spain

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Gliomas

Biomarkers

  • Phosphatase and tensin homolog

  • Epidermal growth factor receptor

Drug/Treatment

  • Temozolomide

  • Erlotinib hydrochloride

  • EGFRvIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved